Premaitha Health Plc (LON:NIPT) is a molecular diagnostics company that has used the latest advances in DNA technology to develop a non-invasive pre-natal screening test. IONA is its first test,
Futura Medical Plc (LON:FUM) has advanced transdermal technology which can be incorporated into formulations of well characterised drugs to improve performance and extend their uses. 2015 was expected to be
Empresaria Group Plc (LON:EMR) has enjoyed a substantial re-rating as the group has delivered against expectations and as profit forecasts have been upgraded. Yet the company continues to be valued
Real Good Food Plc (LON:RGD) is the topic of discussion when DirectorsTalk caught up with Mike Foster, analyst at Hardman & Co. Mike recaps on recent news and discusses share
Real Good Food Plc (LON:RGD) has transformed its prospects through corporate action over the past nine months. The market has yet to catch up with this. Importantly, the mix of business
PPHE Hotel Group Ltd (LON:PPH), the asset-backed, London-focused hotel operator, has announced its Q3 trading update, which show a continuation of the strong trends at the interim results. We revised
Lombard Risk Management Plc (LON:LRM) interims (22nd October) pave the way to a profitable full year FY16, ongoing sales growth. H1 sales growth was 16.1%. Nonetheless, we are trimming our
Empresaria Group Plc (LON:EMR) has announced the acquisition of Pharmaceutical Strategies a provider of temporary workers to the US healthcare sector. The business is currently growing strongly and sector growth
Allergy Therapeutics Plc (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. It has an underlying profitable and cash generative business despite its lead product being
Advanced Oncotherapy Plc (LON:AVO) focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN facility in Switzerland.
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
